Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lifitegrast. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN108084067B offers high-yield Lifitegrast intermediate synthesis. Reduces cost and complexity for pharmaceutical intermediate supply chains globally.
Patent CN118239934A reveals acid-catalyzed debenzylation for Lifitegrast. Achieves high optical purity and cost reduction for pharmaceutical supply chains.
Novel patent CN108129430A offers cost-effective Lifitegrast intermediate synthesis. High yield, scalable process for reliable pharmaceutical intermediate supply chains.
Patent CN111471003A details a novel Negishi coupling route for sitagliptin intermediates, offering high purity and reduced steps for reliable pharmaceutical intermediate supply chains.